Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPressure Tech Regulatory News (PRES)

  • There is currently no data for PRES

Director's Shareholding

22 Jul 2011 15:27

RNS Number : 9277K
Pressure Technologies PLC
22 July 2011
 



Pressure Technologies plc

 

("Pressure Technologies" or the "Company")

 

Director's Shareholding

 

Pressure Technologies announces that Philip Cammerman, Non-executive Director of the Company, today purchased 2,000 ordinary shares in the Company at a price of 160p per share.

 

Following the above acquisition, Mr. Cammerman is now interested in a total of 26,395 ordinary shares in the Company, representing approximately 0.23% of the issued share capital of the Company.

 

Contact:

 

Pressure Technologies plc

John Hayward, Chief Executive

James Lister, Group Finance Director

 

Tel: 0114 242 7500

www.pressuretechnologies.co.uk

 

Fairfax I.S. PLC

Ewan Leggat / Simon Bennett

 

Tel: 0207 598 5368

Rawlings Financial PR Limited

Catriona Valentine

 

Tel: 01653 618 016

www.rawlingsfinancial.co.uk

 

 

Company description:

 

Pressure Technologies is an AIM listed, leading designer and manufacturer of speciality engineering solutions for high pressure systems serving large global markets.

 

The Group's largest subsidiary, Chesterfield Special Cylinders Limited ("CSC") designs, manufactures and offers retesting and refurbishment services for a range of speciality high pressure, seamless steel gas cylinders for global energy and defence markets. The business is conducted under the "Chesterfield" brand which is a long established name in the cylinders and specialised pressure vessel market.

 

Chesterfield BioGas Limited was formed in November 2008 following the signing of a co-operation agreement with Greenlane® Biogas Limited, the world leader in biogas upgrading. This gives Pressure Technologies exclusive rights to market and manufacture Greenlane® equipment in the UK and Eire. Chesterfield BioGas provides turnkey solutions for the cleaning, storage and dispensing of biomethane for injection into the gas grid or use as a vehicle fuel.

 

In 2010, the Engineered Products Division was formed following the purchase of Al-Met Limited ("Al-Met") and the Hydratron group of companies ("Hydratron").

 

Al-Met is a niche manufacturer of specialised, precision engineered valve wear parts used in the oil and gas industries, which was acquired by Pressure Technologies in February 2010. Its products are used in high-pressure choke and flow control valves, designed to regulate flow volumes in extremely demanding applications in the subsea and surface oil and gas industries. The business, which was established in 1985, has developed a leading edge capability in precision machining carbides, high grade stainless steels and super alloys.

 

Hydratron acquired on 15 October 2010, designs, manufactures and sells a range of air operated high pressure hydraulic pumps, gas boosters, power packs, hydraulic control panels and test rigs. Hydratron has sales and manufacturing companies in Altrincham, UK, and Houston, USA and a spread of third party distributors in key locations around the world. Formed in 1981, Hydratron has since established itself as a leading supplier of quality high pressure equipment to the oil and gas industries. The full range of Hydratron products may be viewed at http://www.hydratron.co.uk.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSSEMFLEFFSEEW
Date   Source Headline
13th Jan 20203:36 pmRNSOutcome of Sentencing Hearing
17th Dec 20197:00 amRNSPreliminary Results
5th Dec 20197:00 amRNSPostponement of Sentencing
27th Nov 20197:00 amRNSTrial Verdict
21st Nov 20197:00 amRNSNotice of Results and Trading Update
18th Nov 20197:00 amRNSCommencement of Trial
9th Oct 20197:00 amRNSMajor Contract Win with EDF Energy
25th Jun 20197:00 amRNS2019 Interim Results
7th Jun 20197:00 amRNSNew Adviser Appointments and Interim Results date
6th Jun 20194:30 pmRNSDirectorate Change
4th Jun 20197:00 amRNSCompletion of the sale of Greenlane Biogas
28th May 20197:00 amRNSUpdate on the proposed sale of Greenlane Biogas
13th May 201912:31 pmRNSDevelopment in the proposed sale of Greenlane
30th Apr 20193:22 pmRNSHolding(s) in Company
1st Apr 20197:25 amRNSUpdate on the proposed sale of Greenlane Biogas
27th Mar 20196:20 pmRNSHolding(s) in Company
26th Mar 20195:43 pmRNSHolding(s) in Company
26th Mar 20197:00 amRNSHolding(s) in Company
6th Mar 201911:53 amRNSUpdate on HSE Case - Not Guilty Plea Submitted
28th Feb 20195:14 pmRNSHolding(s) in Company
12th Feb 201912:15 pmRNSResult of AGM
8th Feb 201911:40 amRNSUpdate on Health & Safety Executive Investigation
1st Feb 20197:00 amRNSUpdate on the proposed sale of Greenlane Biogas
16th Jan 20198:00 amRNSPublication of Annual Report and Notice of AGM
11th Dec 20187:00 amRNSFinal Results
10th Dec 20187:00 amRNSProposed sale of Greenlane Biogas
8th Oct 20183:54 pmRNSHolding(s) in Company
4th Sep 20187:00 amRNSDirector/PDMR Shareholding
20th Aug 20184:28 pmRNSPurchase of shares by a Director
17th Aug 20187:00 amRNSDirector/PDMR Shareholding
9th Aug 201812:23 pmRNSHolding(s) in Company
31st Jul 201811:45 amRNSDirector/PDMR Shareholding
31st Jul 20187:00 amRNSBoard Changes
27th Jul 20187:30 amRNSGrant of Share Options
24th Jul 201812:06 pmRNSHolding(s) in Company
3rd Jul 20184:48 pmRNSPurchase of shares by Directors
12th Jun 20187:00 amRNS2018 Interim Results
7th Jun 20184:45 pmRNSSale of Hydratron Limited
30th May 20187:00 amRNSTrading Update
16th Apr 201812:02 pmRNSHolding(s) in Company
13th Feb 20181:05 pmRNSResult of AGM
8th Feb 20187:00 amRNSDirectorate Change
8th Jan 20183:12 pmRNSPublication of Annual Report and Notice of AGM
12th Dec 201711:05 amRNSSecond Price Monitoring Extn
12th Dec 201711:00 amRNSPrice Monitoring Extension
12th Dec 20177:00 amRNSFinal Results
7th Nov 20174:30 pmRNSDirectors Shareholdings
7th Nov 20171:01 pmRNSHolding(s) in Company
3rd Nov 201712:31 pmRNSResult of General Meeting
16th Oct 20174:40 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.